Building Momentum in Bangkok, Embarking on a New Journey
With WHX Labs Bangkok 2026 successfully concluded, the excitement and momentum from the exhibition continue to resonate. As one of Southeast Asia's influential events for laboratory medicine, the exhibition brought together industry experts, partners, and professional visitors from around the world to explore the latest trends and developments in in vitro diagnostics.
Medconn made a strong appearance with multiple product lines and innovative diagnostic solutions. With its distinctive brand identity, innovative products, and comprehensive portfolio of integrated solutions, Medconn emerged as one of the Chinese IVD brands attracting significant attention at the exhibition.
In the Spotlight — Medconn's Brand Identity Draws Wide Attention
During the exhibition, Medconn's booth stood out among the many exhibitors with its distinctive brand design and vibrant, cohesive visual identity, attracting a steady stream of professional visitors for discussions and product consultations.
The booth also caught the attention of the Thai Prime Minister during the official visit to the exhibition hall. The Prime Minister and his delegation stopped by the Medconn booth to learn more about its products and diagnostic solutions, highlighting the growing international visibility and influence of Chinese IVD brands.
The booth not only continued to embody Medconn’s professional, technology-driven, and international brand identity, but also strengthened its visual presence through a consistent brand language. The cohesive use of brand colors, product visuals, and innovative concepts created a distinctive and memorable experience for visitors, further enhancing international customers’ recognition and awareness of the Medconn brand and marking another important step in its global brand development.
New Product Debut — Medconn ML-2000 Introduces a New Experience in HbA1c Testing
One of the highlights of this exhibition was the debut of Medconn’s new ML-2000 HbA1c Analysis Cascade Line, featuring its first public demonstration of a desktop cascade solution. Built around the concept of “Cascade Collaboration for Simpler HbA1c Testing,” the new system delivers an upgraded approach to integrated HbA1c testing.
Designed around the practical needs of clinical laboratories, the ML-2000 can automatically identify HbA1c samples, enable a single operator to manage up to four analyzers, automatically retest flagged samples, and maintain continuous operation even in the event of a single-analyzer failure. These capabilities help improve laboratory efficiency and operational continuity.
The system is available in both desktop and floor-standing cascade configurations, allowing flexible deployment according to laboratory space and testing volumes. While optimizing the use of laboratory space, the two configurations can accommodate a wide range of application scenarios, demonstrating Medconn’s ability to continuously listen to market needs and rapidly translate customer requirements into product innovation.
Beyond its HbA1c portfolio, Medconn also showcased a comprehensive range of product lines covering CLIA chemiluminescence immunoassay, hematology, coagulation, blood gas, clinical chemistry, and POCT. Together, these solutions provide healthcare institutions at different levels with a broader and more integrated IVD portfolio, further demonstrating Medconn’s expanding product capabilities and comprehensive service offering.
Deepening Our Presence in Southeast Asia — Expanding Our Global Market Reach
Southeast Asia has long been a key strategic market in Medconn’s global expansion. Over the years, Medconn has continued to strengthen its presence across the region by actively participating in major industry exhibitions and academic events in Thailand, Malaysia, Vietnam, Indonesia, and other markets. Through ongoing engagement with local partners, healthcare institutions, and industry experts, Medconn has continued to strengthen its regional presence and brand recognition.
From one exhibition to one new connection, and from a single product to a complete diagnostic solution, Medconn remains committed to responding to market needs through innovation and serving customers worldwide with professional expertise.
Looking ahead, Medconn will continue to deepen its presence in Southeast Asia, working closely with local partners to advance innovation in in vitro diagnostics and contribute more Chinese innovation and solutions to global healthcare.
